enVVeno Medical (NASDAQ:NVNO) Posts Earnings Results, Misses Expectations By $0.02 EPS

enVVeno Medical (NASDAQ:NVNO) announced its quarterly earnings data on Thursday. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.02), Zacks reports.

enVVeno Medical Trading Down 0.6 %

Shares of NASDAQ:NVNO traded down $0.02 on Friday, reaching $3.35. 75,755 shares of the company traded hands, compared to its average volume of 103,098. The stock has a market capitalization of $44.66 million, a P/E ratio of -2.60 and a beta of 1.21. The business’s 50-day simple moving average is $4.18 and its 200 day simple moving average is $4.81. enVVeno Medical has a 52 week low of $3.01 and a 52 week high of $6.97.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).